Core Insights - MSCI announced the inclusion of JingTai Technology in the MSCI China Index, effective November 24, 2025, recognizing its innovation in AI and robotics for new drug and material development [1][4]. Group 1: MSCI Inclusion - JingTai Technology is among 26 new stocks added to the MSCI China Index, which includes various resource stocks and technology companies in AI, robotics, semiconductors, and high-end manufacturing [3][4]. - Inclusion in the MSCI China Index signifies entry into the MSCI global standard index series, attracting significant passive investment tracking [4]. Group 2: Company Profile - JingTai Technology is an innovative R&D platform integrating quantum physics, AI, and standardized experimental robotics, focusing on the commercialization of AI in various sectors including pharmaceuticals, energy, agriculture, and new materials [5]. - The company has established partnerships with over 300 international enterprises and research institutions, and aims to achieve profitability in the first half of 2025 [5]. - JingTai Technology is one of the few platforms with high-value collaborations in both AI small molecule and AI biopharmaceutical development, serving 15 of the top 20 global pharmaceutical companies [5].
晶泰科技获纳入MSCI中国指数，全球投资基准认可发展潜力